- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02264483
Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.
Assessment of the Degree of Pneumonia Underdiagnosis in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Using Chest Low-dose Computed Tomography (CT) and Comparison of Inflammatory Profile Between the Two Entities
* Hypothesis: There is an underdiagnosis of pneumonia in COPD (Chronic Obstructive Pulmonary Disease) exacerbations which could be demonstrated by performing low-dose chest CT. Differences in the inflammatory profile in sputum and blood in patients with and without pneumonia can be seen.
* Objective: To assess the degree of underdiagnosis of pneumonia in COPD exacerbations, using chest low-dose CT and to compare clinical and inflammatory differences in blood and sputum between patients with and without pneumonia.
*Material and Methods: Prospective observational study including 75 patients with the diagnosis of COPD at the time of an exacerbation and with criteria for a respiratory tract infection. At the time of inclusion clinical features, blood and sputum analysis, chest X-ray and chest low-dose CT are performed. The investigators divide the patients into two groups according to the existence of pneumonia and the inflammatory pattern in blood (inflammatory markers) and sputum (cell populations and inflammatory markers) is compared between the two branches.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
-
Barcelona, Spanien, 08041
- Rekrytering
- Hospital De La Santa Creu I Sant Pau
-
Kontakt:
- Sebastian
- E-post: lsebastian@santpau.cat
-
Underutredare:
- Laura Sebastian, MD
-
Underutredare:
- Tomas Franquet, MD PhD
-
Underutredare:
- Ana M Giménez, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
INCLUSION CRITERIA
- clinical and spirometric diagnosis of COPD.
- for study group: clinical symptoms of exacerbation and infection of low airway.
- Signed informed consent.
EXCLUSION CRITERIA
- No acceptance of informed consent.
- The STUDY GROUP: treatment with antibiotic more tan 2 days before consultation.
- Another entity known pulmonology other than COPD (non-obstructive disorders, bronchiectasis, interstitial lung disease patients, severe pulmonary hypertension, hypoventilation).
- Chronic treatment with oral corticosteroids or immunosuppressive drug.
- severe organ comorbidity such as cancer in advanced or terminal phase, pulmonary tuberculosis with important involvement, severe pneumoconiosis.
- Severe alteration of nutritional status.
- Heart disease evolved.
- Limitation for understanding the study (including psychiatric disorder, language problem, social or cultural differences, etc.).
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
COPD exacerbation
No intervention. The subjects will be divided in 2 subgroups according to the image study:
|
|
COPD stable patients
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Number of patients with an exacerbation of their disease who have a Pneumonia diagnosed by low dose - CT (not detected by chest X-Ray).
Tidsram: 1 year and a half
|
1 year and a half
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Ingrid Solanes, MD PhD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- IIBSP-EPO-2013-152
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på KOL-exacerbation
-
University Hospital, MahdiaOkändAkut exacerbation CopdTunisien
-
Centre Hospitalier Universitaire, AmiensAvslutadAkut exacerbation CopdFrankrike
-
Shanghai Asclepius Meditec Inc.Shanghai Zhongshan Hospital; Shanghai 10th People's Hospital; The First Affiliated... och andra samarbetspartnersAvslutad
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaOspedale San Donato; Fondazione Salvatore Maugeri; Azienda Unita Sanitaria... och andra samarbetspartnersRekryteringKOL | Hyperkapni | Exacerbation CopdItalien
-
Massachusetts General HospitalResMedAvslutadCopd | KOL-exacerbationFörenta staterna
-
Erasmus Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRekryteringKOL | KOL-exacerbation | Akut Copd-exacerbationNederländerna
-
Texas A&M UniversityAvslutad
-
Hôpital Universitaire Fattouma BourguibaOkändMekanisk ventilation | Copd-exacerbation AkutTunisien, Marocko
-
Beaumont HospitalAerogenAvslutadKronisk obstruktiv lungsjukdom | KOL | KOL-exacerbation | Copd-exacerbation AkutIrland
-
Huashan HospitalOkändVenös tromboembolism | Akut exacerbation CopdKina